IL6 and ovarian carcinoma: LPA1 shares this activity with other LPA receptors as LPA3 also mediates both IL6 and IL8 expressions and LPA2 was identified to be the most efficient receptor in linking LPA to IL-6 and IL-8 production in ovarian cancer cells [24].